期刊文献+
共找到46篇文章
< 1 2 3 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
7
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
氨酚曲马多片联合普瑞巴林胶囊对癌性神经病理性疼痛及睡眠质量的影响分析
10
作者 谢炉峰 冯江 《世界睡眠医学杂志》 2024年第3期496-498,共3页
目的:探讨普瑞巴林胶囊联合氨酚曲马多片治疗癌性神经病理性疼痛的疗效及对患者睡眠质量的影响。方法:选取2021年2月至2023年2月四川省自贡市第四人民医院肿瘤科癌性神经病理性疼痛患者56例进行回顾性分析,根据治疗方法分为对照组和观察... 目的:探讨普瑞巴林胶囊联合氨酚曲马多片治疗癌性神经病理性疼痛的疗效及对患者睡眠质量的影响。方法:选取2021年2月至2023年2月四川省自贡市第四人民医院肿瘤科癌性神经病理性疼痛患者56例进行回顾性分析,根据治疗方法分为对照组和观察组,每组28例。对照组采用普瑞巴林胶囊治疗,观察组采用普瑞巴林胶囊与氨酚曲马多片联合治疗。观察2组爆发痛次数、疼痛程度、不良情绪、睡眠质量、临床疗效以及不良反应。结果:观察组患者的爆发痛次数少于对照组(P<0.05),静息疼痛评分、运动疼痛评分、汉密尔顿焦虑量表(HAMA)评分、汉密尔顿抑郁量表(HAMD)评分、MOS睡眠量表(MOS-SS)中综合睡眠障碍指数(9-items)、睡眠干扰(SLPD)评分均低于对照组(均P<0.05),睡眠量(SLPQ)、睡眠充足度(SLPA)评分均高于对照组(均P<0.05)。观察组患者总有效率为92.86%,对照组总有效率为71.43%,观察组总有效率高于对照组(P<0.05)。观察组不良反应发生率为21.43%,对照组不良反应发生率为17.86%,2组不良反应发生率比较差异无统计学意义(P>0.05)。结论:普瑞巴林胶囊与氨酚曲马多片联合治疗癌性神经病理性疼痛的疗效较单独普瑞巴林胶囊疗效更好,且能改善患者的睡眠质量。 展开更多
关键词 癌性神经病理性疼痛 氨酚曲马多片 普瑞巴林胶囊 疼痛 心理状态 睡眠质量 疗效 不良反应
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
11
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
12
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
不同干预措施对减少全麻苏醒期寒战的对比研究 被引量:10
13
作者 聂玲 魏宏 +2 位作者 刘萍 罗晓敏 吕倩茹 《陕西医学杂志》 CAS 2014年第1期78-80,共3页
目的:探讨不同干预措施对全麻苏醒期寒战的影响。方法:选择100例妇科腹腔镜手术且在苏醒期发生寒战的患者,随机分为四组,每组25例。寒战发生后,A组给予充气式保温毯保暖;B组给予缓慢静脉注射曲马多1mg/kg;C组给予充气式保温毯保暖,缓慢... 目的:探讨不同干预措施对全麻苏醒期寒战的影响。方法:选择100例妇科腹腔镜手术且在苏醒期发生寒战的患者,随机分为四组,每组25例。寒战发生后,A组给予充气式保温毯保暖;B组给予缓慢静脉注射曲马多1mg/kg;C组给予充气式保温毯保暖,缓慢静脉注射曲马多1mg/kg;D组为对照组,给予等量生理盐水静脉注射。观察并记录干预前(T1)、干预后5min(T2)和15min(T3)患者的寒战级别,患者的不良反应(恶心呕吐、头晕等)和返回病房后2h内寒战复发率,以及核心温度(鼓膜温度)的变化。结果:T1时点四组患者寒战程度无显著性差异(P>0.05);T2时点A、B、C组寒战等级低于D组(P<0.05),与A组比较,B、C组寒战疗效更好(P<0.05);T3时点A、B、C组疗效优于D组(P<0.05);A、B、C三组间比较C组疗效最佳(P<0.05)。四组患者各个时间点鼓膜温度无显著性差异(P>0.05)。返回病房后2h内寒战复发率C组明显低于A、B、D组(P<0.05);B、C组不良反应率比较无显著性差异(P>0.05)。结论:充气式保温毯加曲马多,对治疗全麻苏醒期寒战效果显著,不良反应少,且寒战复发率低。 展开更多
关键词 寒战 药物作用 寒战 治疗 曲马朵 治疗应用 @保温毯保暖
下载PDF
阿扎司琼等预防全麻妇科腹腔镜术后寒战100例对比观察 被引量:9
14
作者 肖永 李元涛 +3 位作者 陈桂珊 吴铭广 谷寅 孙晶 《陕西医学杂志》 CAS 2012年第1期72-75,共4页
目的:探讨阿扎司琼与曲马多、哌替啶在预防全身麻醉妇科腹腔镜术后寒战的临床效果。方法:将100例ASA I~II级,拟行妇科全麻腹腔镜择期手术患者随机分为4组,每组25例。A组(阿扎司琼0.15mg/kg),T组(曲马多1mg/kg),P组(哌替啶0.4mg/kg)和... 目的:探讨阿扎司琼与曲马多、哌替啶在预防全身麻醉妇科腹腔镜术后寒战的临床效果。方法:将100例ASA I~II级,拟行妇科全麻腹腔镜择期手术患者随机分为4组,每组25例。A组(阿扎司琼0.15mg/kg),T组(曲马多1mg/kg),P组(哌替啶0.4mg/kg)和对照组(0.9%生理盐水);手术结束时静脉注射给药,记录各组寒战、苏醒及不良反应发生情况。结果:与对照组比较阿扎司琼与曲马多、哌替啶一样可明显减少术后寒战的发生率(P<0.05);阿扎司琼组的苏醒与拔管时间明显短于曲马多组和哌替啶组(P<0.05),不良反应的发生率也少于曲马多组和哌替啶组(P<0.05)。结论:阿扎司琼与曲马多、哌替啶一样用于预防全麻术后寒战是安全可行的。 展开更多
关键词 麻醉 全身 寒战/副作用 寒战/预防和控制 血清素拮抗药/治疗应用曲 马朵/治疗应用 哌替啶/治疗应用 对比研究 腹腔镜检查 手术后期间
下载PDF
氯诺昔康用于烧伤患者切痂植皮术后镇痛的效果观察 被引量:1
15
作者 张娟 郑永辉 黄绍农 《中国误诊学杂志》 CAS 2004年第9期1406-1408,共3页
目的 :评价氯诺昔康用于烧伤患者切痂植皮术后持续静脉镇痛的镇痛效果和副作用。方法 :90例中、重度烧伤患者 ,择期在全麻下行全身多处烧伤切痂植皮手术 ,术后将患者随机分为 3组。芬太尼组 (n=30 ) ,使用芬太尼 1 mg+氟哌啶 3mg+生理... 目的 :评价氯诺昔康用于烧伤患者切痂植皮术后持续静脉镇痛的镇痛效果和副作用。方法 :90例中、重度烧伤患者 ,择期在全麻下行全身多处烧伤切痂植皮手术 ,术后将患者随机分为 3组。芬太尼组 (n=30 ) ,使用芬太尼 1 mg+氟哌啶 3mg+生理盐水至总量 1 0 0 ml持续静脉输注。氯诺昔康组 (n=30 ) ,使用氯诺昔康 32 mg+芬太尼 0 .5 mg+氟哌啶 3mg+生理盐水至总量 1 0 0 ml持续静脉输注。曲马多组 (n=30 ) ,使用曲马多 5 0 0 mg+芬太尼 0 .5 mg+氟哌啶 3mg+生理盐水至总量 1 0 0 ml持续静脉输注。 3组持续输注速率为 2 ml/ h。观察术后镇痛 2 h、4 h和 1 2 h的镇痛效果和副作用。结果 :氯诺昔康组和芬太尼组在术后 2 h和 4 h的镇痛效果优于曲马多组 (P<0 .0 1 ) ;芬太尼组在术后 2 h、4 h和1 2 h的呼吸次数和脉搏血氧饱和度值低于氯诺昔康组和曲马多组 (P<0 .0 5 ) ;曲马多组术后 2 h、4 h的恶心、呕吐发生率高于氯诺昔康组和芬太尼组 (P<0 .0 1 )。结论 :氯诺昔康的镇痛效果优 ,副作用少 。 展开更多
关键词 烧伤/外科学 疼痛 手术后 吡罗昔康/类似物和衍生物 吡罗昔康/治疗应用 芬太尼/治疗应用 曲马朵/治疗应用
下载PDF
曲马多用于患者自控静脉镇痛泵治疗食管癌手术后疼痛的体会 被引量:1
16
作者 王培民 李浩 李建梅 《肿瘤防治杂志》 2003年第7期764-765,共2页
为观察曲马多在食管癌术后患者自控静脉镇痛的效果。将 60例食管癌手术患者分为两组 ,曲马多应用于自控镇痛泵治疗术后疼痛的 3 0例为治疗组 ,传统肌注镇痛 3 0例为对照组。结果镇痛优良率 ,治疗组为 90 %( 2 7 3 0 ) ,对照组为 2 0 %( ... 为观察曲马多在食管癌术后患者自控静脉镇痛的效果。将 60例食管癌手术患者分为两组 ,曲马多应用于自控镇痛泵治疗术后疼痛的 3 0例为治疗组 ,传统肌注镇痛 3 0例为对照组。结果镇痛优良率 ,治疗组为 90 %( 2 7 3 0 ) ,对照组为 2 0 %( 6 3 0 ) 。 展开更多
关键词 曲马朵/治疗应用 镇痛 病人控制 食管肿瘤/外科学 手术后期间
下载PDF
曲马朵与布桂嗪对胸外科患者术后疼痛镇痛效果的比较
17
作者 姚文 郭晓静 于国英 《中国药业》 CAS 2007年第7期48-49,共2页
目的比较曲马朵与布桂嗪的镇痛疗效及安全性,为临床用药提供参考。方法选择胸科手术患者256例,将其随机分为甲组(曲马朵组)和乙组(布桂嗪组),观察两组的疗效、起效时间及持续时间。结果曲马朵组完全缓解32例(25%),显效96例(75%),总有效... 目的比较曲马朵与布桂嗪的镇痛疗效及安全性,为临床用药提供参考。方法选择胸科手术患者256例,将其随机分为甲组(曲马朵组)和乙组(布桂嗪组),观察两组的疗效、起效时间及持续时间。结果曲马朵组完全缓解32例(25%),显效96例(75%),总有效率100%;布桂嗪组完全缓解38例(29.7%),显效90例(70.3%),总有效率100%。结论两组的总有效率均为100%,组间比较无统计学意义。 展开更多
关键词 曲马朵 布桂嗪 镇痛 疗效观察
下载PDF
曲马多、芬太尼单用或与氟哌利多合用对腹腔镜胆囊切除术后镇痛比较 被引量:1
18
作者 马晓旭 李晓梅 +2 位作者 戴体俊 曾因明 邓小明 《陕西医学杂志》 CAS 北大核心 2004年第3期206-208,共3页
目的 :比较曲马多和芬太尼以及它们分别与氟哌利多合用对于腹腔镜下胆囊切除术后病人静脉自控镇痛 ( PCIA)的镇痛效果和不良反应。方法 :96例病人随机分为曲马多组 ( T)、芬太尼组 ( F)、曲马多 +氟哌利多组 ( T+ D)和芬太尼 +氟哌利多... 目的 :比较曲马多和芬太尼以及它们分别与氟哌利多合用对于腹腔镜下胆囊切除术后病人静脉自控镇痛 ( PCIA)的镇痛效果和不良反应。方法 :96例病人随机分为曲马多组 ( T)、芬太尼组 ( F)、曲马多 +氟哌利多组 ( T+ D)和芬太尼 +氟哌利多组 ( F+ D) 4组 ,分别给予 60 0 mg的曲马多、0 .6mg的芬太尼、60 0 mg的曲马多 + 2 .5 mg的氟哌利多和0 .6mg芬太尼 + 2 .5 mg的氟哌利多 ,各用生理盐水稀释至 5 0 ml,进行 PCIA。术后 6、1 2、1 8h分别观察病人的 BP、HR、 RR、镇痛评分 ( VAS)、镇静评分 ( Ramsay)、镇痛药物的使用时间、恶心呕吐评分以及呼吸抑制情况。结果 :在术后 1 2 h内 ,芬太尼的镇痛效果好于曲马多 ,合用氟哌利多并不能增加芬太尼和曲马多的镇痛作用 ,但能降低二者恶心呕吐的发生率 ( P<0 .0 5 )。结论 :对于腹腔镜下施行胆囊切除术的病人 ,术后自控镇痛合用芬太尼和氟哌利多 ,既可以产生良好的镇痛效果 ,又可以减少恶心呕吐的不良反应。 展开更多
关键词 曲马多 芬太尼 氟哌利多 腹腔镜 胆囊切除 术后 镇痛
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
19
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
Probiotic mixture VSL#3:An overview of basic and clinical studies in chronic diseases 被引量:11
20
作者 Fang-Shu Cheng Dan Pan +2 位作者 Bing Chang Min Jiang Li-Xuan Sang 《World Journal of Clinical Cases》 SCIE 2020年第8期1361-1384,共24页
Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted co... Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted considerable attention for its combined effect.VSL#3 is the only probiotic considered as a kind of medical food;it mainly participates in the regulation of the intestinal barrier function,including improving tight junction protein function,balancing intestinal microbial composition,regulating immune-related cytokine expression and so on.The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans(including children).We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies,including digestive systemic diseases(gastrointestinal diseases and hepatic diseases),obesity and diabetes,allergic diseases,nervous systemic diseases,atherosclerosis,bone diseases,and female reproductive systemic diseases. 展开更多
关键词 VSL#3 INTESTINAL barrier function CHRONIC DISEASES INTESTINAL MICROBIAL balance CYTOKINES therapeutic use
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部